| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb213dd5e6765f1b1e91ae24c128e9e8 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ad16df922217338ebaaa0a06be5e7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe27e4ddd5fe58a38e9c20bad95e41f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56bd2d3ec6b64165630f96a869465902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb0d83e73ccd11cfaa672a4165cc190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a60a6c09caa5f07ab9b17b50d9813ca |
| publicationDate |
2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010248179-A |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
Disclosed is a pharmaceutical composition having an effect of inhibiting viral replication by APOBEC3G by suppressing APOBEC3G degradation activity by Vif. The present invention provides a pharmaceutical composition containing as a first active ingredient at least one selected from the group consisting of the following (a) and (b). (A) is a nucleic acid containing a base sequence encoding a polypeptide consisting of the same amino acid sequence as Hsp70, and (b) is a deletion or insertion of one or several amino acids in the amino acid sequence of (a) A nucleic acid comprising a nucleotide sequence consisting of a substituted or added amino acid sequence and encoding a polypeptide having the activity of inhibiting APOBEC3G degradation by Vif. [Selection figure] None |
| priorityDate |
2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |